ClinicalTrials.Veeva

Menu

UK Validation of the Automated "AcceXible" Speech Analysis Software

A

Accexible

Status

Enrolling

Conditions

Mild Cognitive Impairment and Dementia

Treatments

Device: Accexible

Study type

Observational

Funder types

NETWORK
Industry

Identifiers

NCT05534958
AcceXible-Healthy,MCI,Dementia

Details and patient eligibility

About

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating a digital method for detection and follow-up of patients with mild cognitive impairment (MCI) or dementia in a memory clinic setting.

Enrollment

248 estimated patients

Sex

All

Ages

55 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for patients:

  • Adult patients 55+ years of age with suspected MCI or diagnosis of dementia referred into secondary care memory clinic by their General Practitioner.
  • Have English as first language (able to speak and understand verbal messages).
  • Patients must have agreed to participate in the study and have voluntarily signed the informed consent.

Inclusion Criteria for healthy volunteers:

  • Healthy older adults (55+ years of age), without a diagnosis neurological, or psychiatric disorders or any clinical evidence of cognitive decline.
  • Have English as first language (able to speak and understand verbal messages).
  • Controls must have agreed to participate in the study and have voluntarily signed the informed consent.

Exclusion Criteria for patients:

  • To have received a diagnosis of a significant psychiatric disorder or other cognitive impairment not due to neurodegeneration.
  • To have significant vision problems that would affect the ability to perceive visual stimuli.
  • To have significant hearing problems that would affect the ability to understand verbal cues.
  • To be unable to give informed consent to participate in the study.

Exclusion Criteria for healthy volunteers:

  • Objective evidence of significant cognitive decline in any one domain.
  • Score of <88 on ACE-III cognitive testing.

Trial design

248 participants in 3 patient groups

Healthy
Treatment:
Device: Accexible
Mild Cognitive Impairment
Treatment:
Device: Accexible
Early Dementia
Treatment:
Device: Accexible

Trial contacts and locations

1

Loading...

Central trial contact

Carla Zaldua

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems